Information Journal Paper
APA:
Copy. (2019). Antibody-cytokine fusion proteins: A novel class of biopharmaceuticals for the therapy of cancer and of chronic inflammation. New biotechnology, 52(-), 42-53. SID. https://sid.ir/paper/696925/en
Vancouver:
Copy. Antibody-cytokine fusion proteins: A novel class of biopharmaceuticals for the therapy of cancer and of chronic inflammation. New biotechnology[Internet]. 2019;52(-):42-53. Available from: https://sid.ir/paper/696925/en
IEEE:
Copy, “Antibody-cytokine fusion proteins: A novel class of biopharmaceuticals for the therapy of cancer and of chronic inflammation,” New biotechnology, vol. 52, no. -, pp. 42–53, 2019, [Online]. Available: https://sid.ir/paper/696925/en